Analyst Ratings for Zentalis Pharmaceuticals (ZNTL)
ZNTL Rating Summary
ZNTL Price Target Summary
- Highest: $11.00 (Rodman & Renshaw)
- Lowest: $4.00 (Morgan Stanley)
- Average: $7.89
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$7.89 (+257%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
Avg. $ Target:
$7.89 (+257%)
* Over Last 12-Mos
Rating Score: 6.7 / 10
Percentile Rank: 70%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/5/2026 | Leerink | Asthika Goonewardene | New Coverage | Outperform (N/A) |
8.00 (N/A) |
2.52 (2.21) |
-12.3% | Details |
| 9/30/2026 | Wells Fargo | Yanan Zhu | New Coverage | Equal Weight (N/A) |
5.00 (N/A) |
2.71 (2.21) |
-18.45% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
